Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Piramal Pharma Solutions Expands Peptide API Facility with New Spray Drying Suite

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Piramal Pharma Solutions Expands Peptide API Facility with New Spray Drying Suite

Analysed 4 Aug 2026·2 sources analysed·India·Business
Piramal Pharma Solutions Expands Peptide API Facility with New Spray Drying SuitePreviousNext

Piramal Pharma Solutions has expanded its peptide API facility in Turbhe, India, by launching a new spray drying suite with Band 5 containment capacity. This advanced suite, equipped with dedicated air handling, nitrogen supply, and control systems, supports the formulation of complex molecules like peptides and HPAPIs. The spray drying process enhances bioavailability, controls particle size, and preserves molecular integrity while ensuring safe handling of potent compounds through a closed-loop system with specialized safety features.

Sentiment
75%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 38/100.

Outlets measured: thetribune, thehindu. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 4 Aug 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (75/100)

Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

thehindu broke this story on 4 Aug, 10:04 am. Other outlets followed.

4 Aug, 10:04 am2 sources · 5 min4 Aug, 10:09 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
India's Pharma Exports Rise to $31.12 Billion; Maharashtra Contributes 19%
Next →
Ajmera Realty Infra India Reports Q1 FY27 Profit Growth and Management Updates
1
thehindu4 Aug, 10:04 am
Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite
  • 2
    thetribune4 Aug, 10:09 am
    Piramal Pharma Solutions Expands Peptide API Facility with Advanced Spray Drying Suite - The Tribune
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Piramal Pharma LimitedPiramal Pharma SolutionsYapan Bio Private LimitedAbbvie Therapeutics India Private Limited

    Story context

    Category
    Business
    Location
    India
    Sources analysed
    2
    Last analysed
    4 Aug 2026
    Key entities
    APISpray dryingPeptidePurchasing power parityMoleculeIndiaBiomoleculeManufacturingParticle sizeParticleNational Stock Exchange of IndiaBioavailability